125 related articles for article (PubMed ID: 11169925)
1. The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.
Blume AJ; Beasley J; Goldstein NI
Biopolymers; 2000; 55(4):347-56. PubMed ID: 11169925
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Designing scaffolds of peptides for phage display libraries.
Uchiyama F; Tanaka Y; Minari Y; Tokui N
J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
[TBL] [Abstract][Full Text] [Related]
5. Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.
Real E; Rain JC; Battaglia V; Jallet C; Perrin P; Tordo N; Chrisment P; D'Alayer J; Legrain P; Jacob Y
J Virol; 2004 Jul; 78(14):7410-7. PubMed ID: 15220414
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling.
Pearce KH; Iannone MA; Simmons CA; Gray JG
Drug Discov Today; 2004 Sep; 9(17):741-51. PubMed ID: 15450240
[TBL] [Abstract][Full Text] [Related]
7. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
8. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
[TBL] [Abstract][Full Text] [Related]
9. Integrated expressional analysis: application to the drug discovery process.
Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
[TBL] [Abstract][Full Text] [Related]
10. Peptides as tools in drug discovery.
Grøn H; Hyde-DeRuyscher R
Curr Opin Drug Discov Devel; 2000 Sep; 3(5):636-45. PubMed ID: 19649892
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries.
Huang BC; Liu R
Biochemistry; 2007 Sep; 46(35):10102-12. PubMed ID: 17685586
[TBL] [Abstract][Full Text] [Related]
12. The spot technique: synthesis and screening of peptide macroarrays on cellulose membranes.
Winkler DF; Campbell WD
Methods Mol Biol; 2008; 494():47-70. PubMed ID: 18726568
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
14. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
15. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependant cells and its effectiveness in cell-adhesive peptide design.
Kato R; Kaga C; Kunimatsu M; Kobayashi T; Honda H
J Biosci Bioeng; 2006 Jun; 101(6):485-95. PubMed ID: 16935250
[TBL] [Abstract][Full Text] [Related]
16. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling.
Vyroubalova EC; Hartley O; Mermod N; Fisch I
Mol Immunol; 2006 Apr; 43(10):1573-8. PubMed ID: 16280164
[TBL] [Abstract][Full Text] [Related]
17. In vitro protein display in drug discovery.
Lohse PA; Wright MC
Curr Opin Drug Discov Devel; 2001 Mar; 4(2):198-204. PubMed ID: 11378959
[TBL] [Abstract][Full Text] [Related]
18. Design of bioactive and structurally well-defined peptides from conformationally restricted libraries.
Pastor MT; Mora P; Ferrer-Montiel A; Pérez-Payá E
Biopolymers; 2004; 76(4):357-65. PubMed ID: 15386263
[TBL] [Abstract][Full Text] [Related]
19. The ATCG of drug discovery.
Fernandes PB
Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
[TBL] [Abstract][Full Text] [Related]
20. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
Huber W
J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
